Grifols SA ADR (NASDAQ: GRFS) has a price-to-earnings ratio of 35.69x that is above its average ratio. Additionally, the 36-month beta value for GRFS is 0.49. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 1 rating it as “sell.”
The public float for GRFS is 257.30M and currently, short sellers hold a 1.97% ratio of that float. The average trading volume of GRFS on October 04, 2024 was 1.65M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GRFS) stock’s latest price update
Grifols SA ADR (NASDAQ: GRFS)’s stock price has plunge by 1.24relation to previous closing price of 8.84. Nevertheless, the company has seen a 1.82% surge in its stock price over the last five trading sessions. seekingalpha.com reported 2024-10-03 that Grifols, S.A. is undervalued and worth more than its current market valuation, making it a strong buy even without a potential Brookfield buyout. The company leads the global plasma market, with significant growth in immunoglobulin and albumin segments, and has a robust infrastructure and geographical reach. Despite facing competition and emerging technologies, Grifols’ fundamentals are solid, with impressive 2024 earnings forecasts and improving margins and leverage.
GRFS’s Market Performance
GRFS’s stock has risen by 1.82% in the past week, with a monthly drop of -3.76% and a quarterly rise of 27.13%. The volatility ratio for the week is 2.91% while the volatility levels for the last 30 days are 4.36% for Grifols SA ADR The simple moving average for the last 20 days is 0.96% for GRFS stock, with a simple moving average of 14.93% for the last 200 days.
GRFS Trading at 8.31% from the 50-Day Moving Average
After a stumble in the market that brought GRFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.34% of loss for the given period.
Volatility was left at 4.36%, however, over the last 30 days, the volatility rate increased by 2.91%, as shares surge +0.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.78% upper at present.
During the last 5 trading sessions, GRFS rose by +1.82%, which changed the moving average for the period of 200-days by -12.85% in comparison to the 20-day moving average, which settled at $8.87. In addition, Grifols SA ADR saw -22.58% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRFS
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.38 for the gross margin
The net margin for Grifols SA ADR stands at 0.02. The total capital return value is set at 0.05. Equity return is now at value 0.99, with 0.27 for asset returns.
Based on Grifols SA ADR (GRFS), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 1.72. The interest coverage ratio of the stock is 2.18.
Currently, EBITDA for the company is 1.18 billion with net debt to EBITDA at 6.59. When we switch over and look at the enterprise to sales, we see a ratio of 2.19. The receivables turnover for the company is 7.28for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.68.
Conclusion
In conclusion, Grifols SA ADR (GRFS) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
